Synfini offers an AI-driven drug discovery platform that accelerates chemistry design, development, and synthesis. By integrating neuro-symbolic AI with robotic automation and extensive chemistry data, Synfini enables scientists to efficiently create and validate novel therapeutics.
Sector: Biotechnology
Co-investors: Ferocity Capital, WERU Investments